The metabolism of 17 alpha‐ethinyloestradiol by human liver microsomes: formation of catechol and chemically reactive metabolites.

British Journal of Clinical Pharmacology

Volumn 23, Issue 4, 1987, Pages 447-453

  Purba, HS ^a   Maggs, JL ^a   Orme, ML ^a   Back, DJ ^a   Park, BK ^a  

^a UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

CATECHOL; CYTOCHROME P450; ETHINYLESTRADIOL; ETHINYLESTRADIOL H 3; RADIOISOTOPE; UNCLASSIFIED DRUG;

DRUG METABOLISM; HUMAN; HUMAN CELL; LIVER; LIVER MICROSOME; NORMAL HUMAN; PHARMACOKINETICS; PRIORITY JOURNAL;

ADOLESCENT; ADULT; BIOTRANSFORMATION; CATECHOLS; CHILD; CHILD, PRESCHOOL; CYTOCHROME P-450 CYP1A1; ETHINYL ESTRADIOL; FEMALE; HUMANS; KIDNEY TRANSPLANTATION; KINETICS; MALE; MICROSOMES, LIVER; MIDDLE AGED; PROTEIN BINDING; STEROID HYDROXYLASES;

EID: 0023236937     PISSN: 03065251     EISSN: 13652125     Source Type: Journal    
DOI: 10.1111/j.1365-2125.1987.tb03074.x     Document Type: Article

References (35)

1. Estrogen 1,2‐epoxides or estrogen quinones/semiquinones
2. 2‐Hydroxylation of ethinyloestradiol in relation to the oxidation of sparteine and antipyrine
3. Catecholoestrogens (2‐ and 4‐hydroxyoestrogens)‐chemistry, biogenesis, occurrence and physiological significance
4. Irreversible binding of ethinyloestradiol metabolites to protein and nucleic acids as catalysed by rat liver microsomes and mushroom tyrosinase
5. Metabolism of 17α‐ethinylestradiol by human liver microsomes in vitro: Aromatic hydroxylation and irreversible binding of metabolites
6. Effects of insecticide synergists on microsomal oxidation of estradiol and ethynylestradiol and on microsomal drug metabolism
7. Human cytochromes P‐450
8. Attempts to phenotype human liver samples in vitro for debrisoquine 4‐hydroxylase activity
9. Interindividual variation in drug disposition. Clinical implications and methods of investigation
10. Interaction of estrone and estradiol with DNA and protein of liver and kidney in rat and hamster in vivo and in vitro
11. 5
12. 21 steroids in faeces from pregnant women
13. Characterization of rat and human liver microsomal cytochrome P‐450 forms involved in nifedipine oxidation, prototype for genetic polymorphism in oxidative drug metabolism
14. Mephenytoin hydroxylase activity in human liver: Inhibition by steroids
15. Cytochrome P‐450 mono‐oxygenase activities in human and rat liver microsomes
16. 2‐Fluroestradiol: separation of estrogenicity from carcinogenicity
17. Protein measurement with the folin phenol reagent
18. The catechol estrogens
19. Drug‐protein conjugates III. Inhibition of the irreversible binding of ethinylestradiol to rat liver microsomal protein by mixed function oxidase inhibitors, ascorbic acid and thiols
20. 3H]estradiol in the rat: irreversible binding and biliary metabolites
21. 3H]17α‐ethynylestradiol in women
22. Metabolism of phenytoin and ethinylestradiol to reactive metabolites by human liver microsomes
23. Metabolism of stilbene estrogens and steroidal estrogens in relation to carcinogenicity
24. In vitro effects of quinoline derivatives on cytochrome P‐450 and aminopyrine N‐demethylase activity in the rat hepatic microsomes
25. Metabolic activation and drug toxicity
26. Cytochrome P‐450‐mediated oxidation of 2‐hydroxyestrogens to reactive intermediates
27. The carbon‐monoxide‐binding pigment of liver microsomes
28. Inhibition of estrogen 2‐hydroxylase
29. Purification, characterisation and regulation of five rat hepatic microsomal cytochrome P‐450 isozymes
30. Variation in hepatic microsomal cytochrome P‐4501 concentration among untreated rabbits alters the efficiency of estradiol hydroxylation
31. Human liver microsomal cytochrome P‐450 mephenytoin 4‐hydroxylase, a prototype of genetic polymorphism in oxidative drug metabolism
32. The presence of d1, d‐ and 1‐nor‐gestrel and their metabolites in the plasma of women
33. Determination of the mechanisms and constants of inhibition
34. Structure‐activity relationships in the effect of 1‐alkylimidazoles on microsomal oxidation in vitro and in vivo
35. 3H in women. Chromatographic profiling and identification of ethynyl and non‐ethynyl compounds